Please login to the form below
infections
This page shows the latest infections news and features for those working in and with pharma, biotech and healthcare.
Roche’s Tamiflu successor hits the mark in complicated flu
Roche has reported a second pivotal data on a novel influenza drug – baloxavir marboxil – that it says is the first drug with a new mechanism of action for the viral infection ... And that seems to make a big difference to the way flu infection
Latest news
-
Daily Brief: Novartis exits anti-infectives drive, Hancock takes over from Hunt and Trump attacks 'soft Brexit' plan
There is hope that there will be a buyer for its lead candidates, however: LYS228 is in phase II trials for complicated intra-abdominal infection (cIAI) and complicated urinary tract infection
-
Trial data suggest Abivax’ drug may clear latent HIV
from the infection. ... Finding a functional cure for HIV infection that could free patients from the need for chronic therapy is one of the primary objectives for Paris-based Abivax, and it now has
-
Summit plunges after Duchenne disappointment
Its lead product candidate is now ridinilazole a treatment for C difficile infection which is expected to enter phase III clinical trials in Q1 2019.
-
Evotec says Sanofi deal makes it anti-infectives powerhouse
regulatory approvals of course – and that will give it “the highest qualified translational footprint in infectious disease research globally.”It will focus initially on antimicrobial resistant (AMR) infections, tuberculosis, and malaria,
-
Daily Brief, CAR-T update, new leukaemia treatments, universal flu hope and more
Promisingly, it also achieved a reduction in influenza infection rates and severity and duration of symptoms observed, with a 60% reduction in confirmed flu infections and an 83% reduction in the
More from news
Approximately 11 fully matching, plus 891 partially matching documents found.
Latest Intelligence
-
‘How is your day?’
This condition causes chronic lung, ear and sinus infections. Thanks to plasma protein therapies, she says that she no longer worries that the boys will catch an illness that may land ... These are: Primary Immunodeficiency Diseases (PID – causes
-
The threat of antimicrobial resistance
This global research, looking at 13, 000 patients across 66 countries, found that over 12% of those undergoing procedures developed a post-operative surgical site infection (SSI). ... After all, so many of today’s life-saving healthcare advances, from
-
Waking the sleeping giant
learning anatomy, practising operations or even teaching infection control.
-
Significant figures
NTM is a rare progressive, destructive infection that’s normally found in addition to pulmonary diseases such as chronic obstructive pulmonary disease (COPD), cystic fibrosis or bronchiectasis. ... Its novel therapy is an inhaled formulation of
-
Not dying of ignorance - 30 years on
However, rates of infection in the gay community dropped following the campaign.
More from intelligence
Approximately 0 fully matching, plus 41 partially matching documents found.
Latest appointments
-
Nabriva Therapeutics appoints chief medical officer
Nabriva Therapeutics, a biopharma focused on treating bacterial infections, has appointed a new chief medical officer in the form of Jennifer Schranz.
-
Nabriva Therapeutics appoints new chief commercial officer
Bacterial infections focussed Nabriva Therapeutics has appointed Francesco Maria Lavino as its chief commercial officer ahead of the group’s phase III clinical trial for lefamulin - a potential new treatment for ... I am looking forward to working with
-
Germany's Ventaleon names biotech entrepeneur CEO
patients suffering from serious infections such as influenza to get better, faster.
-
Destiny Pharma appoints new CEO
surgical infections from all strains of Staphylococcus aureus, which we believe is a blockbuster opportunity.”.
-
Dr Engelbert Tjeenk Willink joins Allecra Therapeutics
Allecra’s technology provides an important new treatment for hospital clinicians who are grappling with these types of infection.”. ... Hooftman’s new role will see him focus on combating multi drug-resistant Gram-negative bacterial infections.
More from appointments
Approximately 1 fully matching, plus 20 partially matching documents found.
Latest from PMHub
-
Jet Off with Maloff Protect
Therapy area: Infections and Infestations.
-
To track disease, follow the money
including pathogens responsible for pneumonia, blood infections, diarrhoea, and urinary tract and respiratory system infections. ... algorithms, you could quickly gain a picture of how widely and rapidly infection can spread.
-
Design...
As an example, Boscart and colleagues3 used behavioural change theory to understand barriers in good hand hygiene among nurses to prevent the spread of infections, and design interventions that would actually
-
Antibiotic Resistance: Alarm bells ring louder than ever
in day-to-day use and routine medical procedures no longer being able to cure simple bacterial infections. ... related to bacterial infection that we have become so accustomed to and complacent about.
-
Vivotif from PaxVax: Helping to keep you safe
Therapy area: Infections and Infestations.
More from PMHub
Approximately 2 fully matching, plus 29 partially matching documents found.
Featured jobs
- Head of Market Access - International - Based Cambridge
-
Excellent Basic, Bonus and Flex Benefits
- Business Unit Head, Medical Communications, London
-
Excellent package
- Home based, Senior Medical Writer, Medical Communications
-
Excellent package
- Principal Medical Writer / Editorial Director – Medical Communic...
-
£60, 000 - £80, 000
- Home based, Chief Medical Writer, Medical Communications
-
Excellent package
- Account Director, Medical Communications
-
C£50 – 65, 000 benefits and bonus
- Home based, Principal Medical Writer, Medical Communications
-
Excellent package
-
Client Services Director - Med Comms
-
Great salary and bebefits
- Account Director, Consumer Healthcare PR, Global PR agency
-
£50, 000 – £58, 000
- Strategic Planner, Healthcare Advertising
-
£47, 000 – £53, 000
- Account Manager, Medical Communications and Marketing
-
£30, 000 – £40, 000 benefits and bonus
- Senior Medical Writer, Healthcare Advertising Agency
-
£45, 000 – £50, 000
-
Account Manager
-
£40, 000 - £45, 000 benefits
- Home based, Editorial Team Leader, Medical Communications
-
Excellent package
-
Healthcare PR Director
-
£100, 000 – £120, 000 benefits
Subscribe to our email news alerts
- Moving annual total (MAT)
- Brexit rebels win vote on European Medicines Agency alignment
- MaxCyte gets green light for solid tumour cell therapy
- Communiqué Awards 2018: Photo Gallery - Communiqué Awards 2016
- NHS England to Vertex: come clean on Orkambi offer
- AstraZeneca joins Merck in Brexit stockpiling effort
- Random42 win Creativity International Award for Scientific Animation
- Merck & Co joins big pharma pricing pledge – but sceptics unconvinced
- Aurora partners with PIPHealth and taps into patient panels
- FDA’s Gottlieb lambasts industry’s biosimilar-blocking tactics
- Allergan’s abicipar matches AMD blockbuster Lucentis in phase III
- OUTiCO growth in multi-channel creates more job openings
PMHub
Four Health Communications
Formerly known as Packer Forbes Communications, Four Health Communications is an award-winning, integrated healthcare communications agency for pharma, biotech, NGOs...
Latest intelligence
- Developing advocacy in the pharmaceutical industry.
- The importance of advocacy programmes...
- GDPR and events. What does the pharma industry need to know?
- Many people in the pharma industry still aren’t following the rules set out by the GDPR when it comes to running events and attending tradeshows. But with eye-watering fines for...
- Digital trends in B2B sales - how far behind is Pharma?
- The modern approach to B2B sales is data-driven, and enabled by digital tools....
Quick links
Infographics
